Russia became the first country to register the world’s first COVID-19 vaccine on August 11
Moscow:
The price per dose of the Russian Sputnik V coronavirus vaccine will be much lower than that of the vaccines from US pharmaceutical giants Pfizer and Moderna, the official Russian vaccine Twitter account said on Sunday.
“Translating pharmaceutical jargon: Pfizer’s advertised price of $ 19.50 and Moderna of $ 25 to $ 37 per dose actually means their price of $ 39 and $ 50 to $ 74 per person. Two doses per person are required to the Pfizer, Sputnik Vaccines V and Moderna. The price of Sputnik V will be much lower, “said the official account.
Translating pharmaceutical jargon: Pfizer’s advertised price of $ 19.50 and Moderna of $ 25- $ 37 per dose actually means their price of $ 39 and $ 50- $ 74 per person. Two doses per person are required for the Pfizer, Sputnik V, and Moderna vaccines. The price of the Sputnik V will be much lower. https://t.co/nr1C7RBdZB
– Sputnik V (@sputnikvaccine) November 22, 2020
Russia became the first country to register the world’s first COVID-19 vaccine on August 11. Sputnik V was developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Ministry of Health.
On November 11, Russia said its Sputnik V vaccine is 92 percent effective in protecting people from COVID-19 according to the first interim analysis.
On November 17, Moderna, in its official statement, had announced that the independent Data Security Monitoring Board (DSMB), designated by the US NIH for the Phase 3 study of mRNA-1273, informed Modern that the trial met the statistical criteria specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%.
Similarly, on November 18, Pfizer had said that the final results of the last stage of the trial of its coronavirus vaccine were found to be 95 percent effective and had no serious side effects in older people.
(Except for the headline, this story has not been edited by NDTV staff and is posted from a syndicated channel)
.
